Shopping Cart
Remove All
Your shopping cart is currently empty
Enfortumab vedotin-ejfv (Padcev) is an ADC compound targeting Nectin-4 with anti-tumor activity, used in the study of urothelial carcinoma.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $793 | In Stock | In Stock | |
| 5 mg | $2,300 | - | In Stock | |
| 10 mg | $3,120 | - | In Stock | |
| 25 mg | $4,630 | - | In Stock |
| Description | Enfortumab vedotin-ejfv (Padcev) is an ADC compound targeting Nectin-4 with anti-tumor activity, used in the study of urothelial carcinoma. |
| In vitro | Enfortumab vedotin-ejfv is a fully human IgG1-kappa antibody linked to the microtubule-disrupting monomethyl auristatin E (MMAE) through a protease-cleavable maleimidocaproyl-valine-citrulline linker (SGD-1006) [2]. |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | MMAE |
| Gene ID | |
| Uniprot ID | |
| Target | Nectin-4 |
| Molecular Weight | 143.9 kDa |
| Cas No. | 1346452-25-2 |
| Isotype | IgG1 kappa-MMAE |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.